XW133YBTransfusion of Nonautologous (Human) Fibrinogen Concentrate, Shelf-stable into Peripheral Vein, Percutaneous Approach, New Technology Group 11

New Technology›Anatomical Regions›Transfusion
  • Billable / Specific Code
ICD-10-PCS XW133YB
CMS Source: FY 2027 ICD-10-PCS dataset. Effective Oct 1, 2026 – Sep 30, 2027.FacebookXLinkedInPrint

XW133YB is a billable ICD-10-PCS procedure code for Transfusion of Nonautologous (Human) Fibrinogen Concentrate, Shelf-stable into Peripheral Vein, Percutaneous Approach, New Technology Group 11. It is valid on HIPAA claims for fiscal year 2027 (October 1, 2026 through September 30, 2027). The root operation Transfusion involves putting in blood or blood products. In AHRQ's Clinical Classifications Software (CCSR), this procedure falls under Transfusion of clotting factors.

Code Identity

ICD-10-PCS Code
XW133YB
Billable Status
Yes — Valid for Submission
Code Describes
Transfusion of Nonautologous (Human) Fibrinogen Concentrate, Shelf-stable into Peripheral Vein, Percutaneous Approach, New Technology Group 11
Short Description
Transfuse Fibrgn Shf-stbl in Periph Vein, Perc, New Tech 11
Parent Code
XW1

PCS Table Breakdown

Each ICD-10-PCS code is built from seven characters, each an axis of the procedure. Hover or tap the icons for the official CMS definitions.

PositionDesignationValueMeaning
1SectionXNew Technology
2Body SystemWAnatomical Regions
3Operation1Transfusion
4BodyPart3Peripheral Vein
5Approach3Percutaneous
6Device/Substance/TechnologyYNonautologous (Human) Fibrinogen Concentrate, Shelf-stable
7QualifierBNew Technology Group 11

In the ICD-10-PCS Alphabetic Index

These FY 2027 ICD-10-PCS Alphabetic Index entries lead to this code:

FIBRYGA
Anatomy or device term that leads here
Omidubicel
Leads to this code's table
Autotransfusion
Leads to this code's table
Atidarsagene Autotemcel
Leads to this code's table
Betibeglogene Autotemcel
Leads to this code's table
Exagamglogene Autotemcel
Leads to this code's table
Mozafancogene Autotemcel
Leads to this code's table
Marnetegragene Autotemcel
Leads to this code's table
New Technology, Omidubicel
Leads to this code's table
Lovotibeglogene Autotemcel
Leads to this code's table
Transfusion, New Technology
Leads to this code's table
Administration, Blood products
Leads to this code's table
Convalescent Plasma (Nonautologous)
Leads to this code's table
Plasma, Convalescent (Nonautologous)
Leads to this code's table
New Technology, Atidarsagene Autotemcel
Leads to this code's table

To code new technology of the omidubicel, open the FY 2027 ICD-10-PCS Alphabetic Index at New Technology, then the subterm Omidubicel. The index leads to table XW1, where the approach, Device/Substance/Technology and qualifier values shown in the breakdown above complete the seven-character code XW133YB.

Browse the full ICD-10-PCS Alphabetic Index →

Clinical Classification (CCSR)

AHRQ groups this procedure code into these clinical categories.

ADM004
Transfusion of clotting factors
Clinical domain: Administration of Therapeutic Substances

Code History

Replaces previously assigned code(s):
  • 30233T1 — Transfuse Nonaut Fibrinogen in Periph Vein, Perc

Similar Procedure Codes

Questions About XW133YB

Is XW133YB a billable code?

Yes. This is a complete seven-character ICD-10-PCS code, specific enough to report Transfusion of Nonautologous (Human) Fibrinogen Concentrate, Shelf-stable into Peripheral Vein, Percutaneous Approach, New Technology Group 11 on inpatient claims from October 1, 2026 through September 30, 2027.

What do the characters in XW133YB mean?

The code breaks down character by character: the 1st character X is the Section (New Technology); the 2nd character W is the Body System (Anatomical Regions); the 3rd character 1 is the Operation (Transfusion); the 4th character 3 is the BodyPart (Peripheral Vein); the 5th character 3 is the Approach (Percutaneous); the 6th character Y is the Device/Substance/Technology (Nonautologous (Human) Fibrinogen Concentrate, Shelf-stable); the 7th character B is the Qualifier (New Technology Group 11).